Health Risk Factor Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Risk Factor Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
G. d'Annunzio University, Chieti
Enhanced platelet activation occurs in colorectal cancer patients
March 22nd, 2005
Researchers have investigated platelet activation in patients with colorectal cancer. According to scientists in Italy, "Aspirin may reduce the risk of colorectal neoplasia at doses similar to those recommended for the prevention of cardiovascular disease. Thus, we aimed to address whether enhanced platelet activation, as assessed by the measurement of the urinary, excretion of 11-dehydro-TXB2 (a major enzymatic metabolite of TXB2), occurs in patients with colorectal cancer." M.G. Sciulli and colleagues of G. d'Annunzio University in Chieti explained, "In 10 patients with colorectal cancer, the urinary excretion of 11-dehydro-TXB2 was significantly...
Source: Health Risk Factor Week (2005-03-22)
|
